Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 9161 - 9165 of 9165 results

First page
Previous page
917
Next page disabled
Next page disabled

TB-403

46MVG4H2LF

Status:

Investigational

Source:

NCT03669393: Phase 2 Interventional Completed Retinal Telangiectasis

(2018)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03669393

Class:

CONCEPT

CDX-014

GJV1PP34M2

Status:

Investigational

Source:

NCT02837991: Phase 1 Interventional Terminated Renal Cell Carcinoma (RCC)

(2016)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT02837991

Class:

CONCEPT

HKT-288

94ZE6ON35F

Status:

Investigational

Source:

NCT02947152: Phase 1 Interventional Terminated Epithelial Ovarian Cancer

(2016)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT02947152

Class:

CONCEPT

ILUNOCITINIB

N3TB5AH8B9

Status:

Investigational

Source:

INN:ILUNOCITINIB [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/N3TB5AH8B9

Class:

CONCEPT

MIK-665

801XYWHNOS

Status:

Investigational

Source:

NCT03672695: Phase 1 Interventional Recruiting Acute Myeloid Leukaemia

(2018)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03672695

Class:

CONCEPT

Concept

TB-403

Concept

CDX-014

Concept

HKT-288

Concept

Concept

MIK-665

Showing 9161 - 9165 of 9165 results

First page
Previous page
917
Next page disabled
Next page disabled

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1